IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Illinois at Chicago
- Study ID
- NCT06266416
- Status
- Recruiting
Conditions
- HIV Infections
- Sexual Behavior
- Sexually Transmitted Infections (Not HIV or Hepatitis)
Eligibility Criteria
- Sex
- ALL
- Age
- 13 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- IMARA for Black Male Caregivers and Girls Empowerment — BEHAVIORALIMAGE is delivered by trained Black female facilitators to improve girls' SRH outcomes, prevention HIV/STIs, and reduce sexual violence. Over the two days, some components of the curriculum are delivered separately to male caregivers and girls, covering parallel content, and other sections are delivered jointly in a single group. The curriculum, extensively tailored for the target population and pilot tested, addresses Black girls' sexual development, risk for sexual violence, female anatomy, body positivity, HIV/STI knowledge and attitudes, and condom use. IMAGE is designed to strengthen bonds and communication between male caregivers and girls by encouraging perspective-taking (i.e., reverse role play) and conflict resolution.
- Time-matched control program — BEHAVIORALFUEL will engage Black male caregivers and girls to promote good nutrition, exercise, and informed consumer behavior. Topics include the impact of media on body image, evaluating nutritional labels to make healthy food choices, eating balanced meals, establishing regular exercise routines, and how families and communities can support healthy behavior. FUEL includes a brief video about HIV/AIDS and other STIs but otherwise does not otherwise address sexual health. Like IMAGE, FUEL is delivered in groups of 6-8 dyads over two workshop days (\~10 hours total) in one weekend. Parts of the curriculum are delivered separately to girls and male caregivers covering parallel content and other components are delivered jointly.
Study Details
The scientific premise of this research is that individual, interpersonal, and structural factors impact Black girls' sexual reproductive health outcomes (sexually transmitted infection (STI) and Human Immunodeficiency Virus (HIV)) and experience of sexual violence. This study expands STI/HIV prevention programs to include Black male caregivers, a potentially valuable yet underutilized resource to protect Black girls and reduce their exposure to STI/HIV and sexual violence.
Key Dates
- Start date
- Sep 2, 2024
- Status verified
- Apr 2026
- Primary completion
- Jul 30, 2027
- Completion
- May 31, 2028
Study Design
- Enrollment
- 612 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Experimental (IMAGE) GroupThe IMAGE group will receive an 8-10-hour HIV/STI group-based (6-8 dyads) prevention program delivered to Black male caregivers and girls over 2-days.
- Active Comparator: Control (FUEL) GroupThe FUEL group will receive a caregiver-adolescent general health promotion program identical in length and intensity to IMAGE.
Primary Outcome Measure
STI Incidence in Participants [ Time Frame: 6 and 12 months post treatment ]
Central Contacts
- Natasha Crooks, PhD312-996-5801
- Jessica Ogwumike, MPH7739839980
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Illinois Chicago | Chicago | Illinois | 60612 |
Find similar trials in Chicago, IL
By condition
By specialty
By research site
Related Studies
- Keeping it LITE: Exploring HIV Risk in Vulnerable Youth With Limited Interaction and Digital Health InterventionRecruiting · Hektoen Institute for Medical Research · Chicago, Illinois
- Testing a Real-time Electronic Antiretroviral Adherence Monitoring InterventionPHASE3 · Recruiting · University of Illinois at Chicago · Chicago, Illinois
- A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1PHASE3 · Recruiting · ViiV Healthcare · Birmingham, Alabama
- Dasatinib for HIV-1 Reservoir ReductionPHASE1 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Chicago, Illinois